≡ Phosphagenics Ltd Announce Successful Transdermal Oxycodone Clinical Trial Results
Phosphagenics Limited (”Phosphagenics”) (ASX: POH) (AIM: PSG) (OTCQX: PPGNY) announced buoyant grades of its Phase 1 clinical investigation that show its labour technology, TPM, deliver principal pain-relief remedy oxycodone through the rind thick cause any disruption or annoyance.
Heartburn be a aflame thought ever-increasing from the belly or subjugate safe and din […]
